Eagle Pharmaceuticals
EGRX
#8886
Rank
S$72.07 M
Marketcap
$5.56
Share price
-0.23%
Change (1 day)
-73.38%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): S$47.6 M

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are S$46.44 M. In 2022 the company made an earning of S$85.8 M an increase over its 2021 earnings that were of -S$3.8 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) S$47.6 M-44.52%
2022 S$85.8 M-2361.45%
2021 -S$3.8 M-111.53%
2020 S$32.89 M2.31%
2019 S$32.15 M-32.89%
2018 S$47.9 M-50.35%
2017 S$96.49 M38.63%
2016 S$69.6 M1966.43%
2015 S$3.36 M-111.46%
2014 -S$29.41 M282.82%
2013 -S$7.69 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$26.40 B 56,752.41%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.16 B 17,482.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$14.19 B 30,464.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$1.07 B 2,219.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
S$4.59 B 9,785.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$11.70 B 25,109.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$8.37 B-18,101.07%๐Ÿ‡บ๐Ÿ‡ธ USA